FOXM1 and neoplasm: Interestingly, it was observed that FOXM1 inhibitors alone or in combination with cisplatin showed synergistic anti-tumor response in naïve and CR-SCLC cell line (Fig. 6B–C, supplementary Fig. S13, S14A).